I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Kishtagari, A.
78
results:
Search for persons
X
Format
Online (78)
Mediatypes
Articles (Online) (40)
Bookchapter (Online) (1)
OpenAccess-fulltext (37)
Sorted by: Relevance
Sorted by: Year
?
1
Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III:..:
Watts, J.
;
Smith, B.
;
Bradley, T.
...
Leukemia Research. 128 (2023) - p. 107272 , 2023
Link:
https://doi.org/10.1016/..
?
2
P1005: A PHASE 1, OPEN-LABEL, DOSE-ESCALATION STUDY OF SELI..:
Ali, H.
;
Kishtagari, A.
;
Maher, K.
...
HemaSphere. 6 (2022) - p. 895-896 , 2022
Link:
https://doi.org/10.1097/..
?
3
P587: COVALENT-101: A PHASE 1 STUDY OF BMF-219, A NOVEL ORA..:
Ravandi-Kashani, F.
;
Kishtagari, A.
;
Carraway, H.
...
HemaSphere. 6 (2022) - p. 486-487 , 2022
Link:
https://doi.org/10.1097/..
?
4
Cost-Effective and Scalable Clonal Hematopoiesis Assay Prov..:
Mack, Taralynn
;
Vlasschaert, Caitlyn
;
von Beck, Kelly
...
The Journal of Molecular Diagnostics. 26 (2024) 7 - p. 563-573 , 2024
Link:
https://doi.org/10.1016/..
?
5
Driver mutation zygosity is a critical factor in predicting..:
Kishtagari, Ashwin
;
Khan, M. A. Wasay
;
Li, Yajing
...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
6
Venetoclax and hypomethylating agents in octogenarians and ..:
Madarang, Ellen
;
Lykon, Jillian
;
Zhao, Wei
...
Blood Neoplasia. 1 (2024) 2 - p. 100016 , 2024
Link:
https://doi.org/10.1016/..
?
7
Clonal hematopoiesis and inflammation in the vasculature: C..:
Shannon, Morgan L.
;
Heimlich, J. Brett
;
Olson, Sydney
...
Blood Advances. 8 (2024) 13 - p. 3453-3463 , 2024
Link:
https://doi.org/10.1182/..
?
8
Distinct bone marrow findings associated with a noncanonica..:
Allison, Devin R.
;
Dholaria, Bhagirathbhai
;
Kishtagari, Ashwin
...
American Journal of Hematology. 99 (2024) 7 - p. 1400-1402 , 2024
Link:
https://doi.org/10.1002/..
?
9
P-213 COVALENT-101: phase I study of BMF-219, a covalent me..:
Rosenberg, Aaron
;
Baljevic, Muhamed
;
Amor, Adrian Alegre
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S152-S153 , 2023
Link:
https://doi.org/10.1016/..
?
10
POSTER: MPN-336 Selinexor Plus Ruxolitinib in JAK Inhibitor..:
Ali, Haris
;
Kishtagari, Ashwin
;
Maher, Keri
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S195 , 2023
Link:
https://doi.org/10.1016/..
?
11
MPN-336 Selinexor Plus Ruxolitinib in JAK Inhibitor (JAKi) ..:
Ali, Haris
;
Kishtagari, Ashwin
;
Maher, Keri
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S389 , 2023
Link:
https://doi.org/10.1016/..
?
12
Patient-specific comorbidities as prognostic variables for ..:
Sochacki, Andrew L.
;
Bejan, Cosmin Adrian
;
Zhao, Shilin
...
Blood Advances. 7 (2023) 5 - p. 756-767 , 2023
Link:
https://doi.org/10.1182/..
?
13
TP53 Mutations Are Associated with Increased Infections and..:
Marvin-Peek, Jennifer
;
Mason, Emily F.
;
Kishtagari, Ashwin
...
Transplantation and Cellular Therapy. 29 (2023) 6 - p. 390.e1-390.e10 , 2023
Link:
https://doi.org/10.1016/..
?
14
AML-522 COVALENT-101: Phase I Study of BMF-219, a Covalent ..:
Ravandi, Farhad
;
Lancet, Jeffrey
;
Amor, Adrian Alegre
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S310-S311 , 2023
Link:
https://doi.org/10.1016/..
?
15
POSTER: AML-522 COVALENT-101: Phase I Study of BMF-219, a C..:
Ravandi, Farhad
;
Lancet, Jeffrey
;
Amor, Adrian Alegre
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S171 , 2023
Link:
https://doi.org/10.1016/..
1-15